|
|
|
Volumn 273, Issue 5273, 1996, Pages 302-303
|
|
Chemokines share center stage with drug therapies
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD4 ANTIGEN;
CHEMOKINE;
RANTES;
ANTIVIRUS AGENT;
CHEMOKINE RECEPTOR CCR5;
CYTOKINE RECEPTOR;
VIRUS RECEPTOR;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ANTIVIRAL ACTIVITY;
CONFERENCE PAPER;
DRUG SYNTHESIS;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOTHERAPY;
PRIORITY JOURNAL;
VIRUS INHIBITION;
VIRUS REPLICATION;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
DRUG ADMINISTRATION;
DRUG COMBINATION;
DRUG EFFECT;
HUMAN;
IMMUNOLOGY;
METABOLISM;
PHYSIOLOGY;
VIROLOGY;
ACTIVE IMMUNIZATION;
DRUG EFFICACY;
NOTE;
SEROCONVERSION;
TREATMENT OUTCOME;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTIVIRAL AGENTS;
CHEMOKINES;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
HIV;
HUMANS;
RECEPTORS, CCR5;
RECEPTORS, CYTOKINE;
RECEPTORS, HIV;
|
|
EID: 0029904198
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (0)
|